` PCIB (PCI Biotech Holding ASA) vs Oslo OBX Comparison - Alpha Spread

PCIB
vs
O
Oslo OBX

Over the past 12 months, PCIB has underperformed Oslo OBX, delivering a return of -80% compared to the Oslo OBX's +17% growth.

Stocks Performance
PCIB vs Oslo OBX

Loading
PCIB
Oslo OBX
Add Stock
www.alphaspread.com

Performance Gap
PCIB vs Oslo OBX

Performance Gap Between PCIB and OBX
HIDDEN
Show

Performance By Year
PCIB vs Oslo OBX

Loading
PCIB
Oslo OBX
Add Stock

Competitors Performance
PCI Biotech Holding ASA vs Peers

Oslo OBX
PCIB
ABBV
AMGN
GILD
VRTX
Add Stock

PCI Biotech Holding ASA
Glance View

Market Cap
12.9m NOK
Industry
Biotechnology

PCI Biotech Holding ASA engages in the research and development of biopharmaceutical products for cancer treatment. The company is headquartered in Oslo, Oslo. The company went IPO on 2008-06-18. Its activities are focused on the commercialization of a patented photochemical drug delivery technology for use in the localized cancer treatment. The Company’s products are based on the Photochemical Internalization (PCI) technology for light-directed drug delivery, used to enhance the effect of drugs by targeted illumination of the diseased areas of the body. The company focuses primarily on the drug candidate Amphinex, developed for treatment of head and neck cancer and bile duct cancer, as well as on the development of PCI for vaccination. As of December 31, 2011, it had a wholly owned subsidiary PCI Biotech AS and an affiliate PCIO Biotech Utibu, located in Iceland.

PCIB Intrinsic Value
HIDDEN
Show
Back to Top